Matches in Wikidata for { <http://www.wikidata.org/entity/Q63316975> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q63316975 description "clinical trial" @default.
- Q63316975 description "ensayu clínicu" @default.
- Q63316975 description "klinisch onderzoek" @default.
- Q63316975 description "клінічне випробування" @default.
- Q63316975 description "կլինիկական փորձարկում" @default.
- Q63316975 name "Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q63316975 type Item @default.
- Q63316975 label "Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q63316975 prefLabel "Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q63316975 P1050 Q63316975-5C674A7A-100F-4231-B6BA-E99F1B86DD04 @default.
- Q63316975 P1132 Q63316975-9F6DEF6E-72E9-4DDF-BE32-613DA91926AF @default.
- Q63316975 P1476 Q63316975-EC3B770D-27B4-4CC8-979D-C9206CF2E556 @default.
- Q63316975 P17 Q63316975-8785CC79-534A-4676-AEF1-74F3153789D9 @default.
- Q63316975 P2899 Q63316975-90CC7478-0BAB-4DA1-90B6-B3434CD4E8F2 @default.
- Q63316975 P3098 Q63316975-0E335263-9E17-44DD-8A7D-09AAEEBAFB7A @default.
- Q63316975 P31 Q63316975-9A43F013-A433-45F5-8055-EA7E59BD98EC @default.
- Q63316975 P4844 Q63316975-13198BAA-D5D0-4C0E-9456-06C88B890242 @default.
- Q63316975 P4844 Q63316975-4A0633BF-466F-4DA6-B4CD-170D80EC9147 @default.
- Q63316975 P4844 Q63316975-FA1CC35F-A097-4E72-AFBA-0469EC34A0F8 @default.
- Q63316975 P580 Q63316975-21E99C38-FCE3-458F-9830-EB926E31937B @default.
- Q63316975 P582 Q63316975-8EE1C684-FCC8-43C5-8444-87F93BE49A04 @default.
- Q63316975 P6099 Q63316975-C6A538BC-684E-4B43-9C64-86E6D804BDE6 @default.
- Q63316975 P6153 Q63316975-F8D6B987-122F-428B-8A20-591ABCB6A54E @default.
- Q63316975 P8363 Q63316975-3AE3607A-FA40-4910-B2AD-889C9390558B @default.
- Q63316975 P859 Q63316975-3B4156B4-ED30-498A-9ECF-320D6EF2CEF6 @default.
- Q63316975 P1050 Q29496 @default.
- Q63316975 P1132 "+160" @default.
- Q63316975 P1476 "Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q63316975 P17 Q30 @default.
- Q63316975 P2899 "+60" @default.
- Q63316975 P3098 "NCT01515527" @default.
- Q63316975 P31 Q30612 @default.
- Q63316975 P4844 Q1181878 @default.
- Q63316975 P4844 Q180983 @default.
- Q63316975 P4844 Q414030 @default.
- Q63316975 P580 "2012-02-01T00:00:00Z" @default.
- Q63316975 P582 "2020-02-01T00:00:00Z" @default.
- Q63316975 P6099 Q42824440 @default.
- Q63316975 P6153 Q1525831 @default.
- Q63316975 P8363 Q78089383 @default.
- Q63316975 P859 Q1525831 @default.